Difficulty: Medium
Average Score: 68%
Practice
A researcher is studying the bioavailability of commonly used antimuscarinics to treat irritable bowel syndrome. Medication A is administered in a $100 \mathrm{mg}$ daily dose orally and $60 \mathrm{mg}$ of the drug is absorbed from the gastrointestinal tract unchanged. Thus, the bioavailability of Medication A is
Correct answer
B
Rationale
The bioavailability of Medication A is $60\%$ (B). Bioavailability (F) = (Amount absorbed unchanged / Dose) ├âãÆ├óÔé¼ÔÇØ 100 = (60 mg / 100 mg) ├âãÆ├óÔé¼ÔÇØ 100 = $60\%$. Options A (50\%), C (70\%), D (80\%), and E (90\%, original) miscalculate. This reflects the fraction reaching systemic circulation intact (e.g., avoiding first-pass metabolism), typical for antimuscarinics (e.g., hyoscyamine), guiding dosing for IBS, where GI absorption and hepatic metabolism determine efficacy, a key pharmacokinetic metric.